News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
First Call 'Healthcare of the Future' now Open - European Partnership 'Transforming Health and Care Systems'
The European Partnership Transforming Health and Care Systems (THCS) has opened its first Joint Transnational Call for proposals aiming to encourage the optimization of patient care pathways and contribute to the transition towards more sustainable, efficient, resilient, ethical, high-quality, and accessible person-centered healthcare systems. More than 30 funding agencies participate with an indicative budget of more than €30 million.
Companies based in Flanders are eligibile to apply for funding. Flemish research organisations, higher and secondary education organisations can only participate as research partner or subcontractor of a Flemish company. For a project to be eligible, enterprises must request at least €25,000 and at most €500.000 subsidy.
For general informtion on the call, visit the THCS webpage (including the full call text and guidance for applicants) here. On this page, you can rewatch a recently held information webinar on the Call. The deadline for the obligatory Intent to apply submission is 23 May 2023. Deadline for proposal submission is 13 June 2023.
In addition to the centrally submitted THCS project application form, partners from Flanders need to submit an application to VLAIO. Interested parties based in Flanders are invited to contact the VLAIO advisors to get support: Contact us for tailor-made advice | Agentschap Innoveren en Ondernemen (vlaio.be).
Related News
|
2024-04-26
|
5 days ago |
Opportunity to join the European Cancer Imaging Initiative |
|
2024-04-26
|
5 days ago |
Call for tender: Platform for Advanced Virtual Human Twin (VHT) Models |
|
2024-04-25
|
6 days ago |
Cluster Health - Number of submitted proposals (deadline 11 April) |
|
2024-04-23
|
1 week ago |
Horizon Europe work programme admendments - changes for the Health Cluster & new Ca... |
|
2024-04-19
|
1 week ago |
Cascade funding: DigitalHealthUptake Call for Training |
|
2024-04-17
|
2 weeks ago |
Global Health EDCTP3 - Submitted proposals 2024 two-stage calls |
|
2024-04-17
|
2 weeks ago |
Innovative Health Initiative Call 6 - Number of submitted proposals |
|
2024-04-17
|
2 weeks ago |
Feedback opportunity for Horizon Europe work programme 2025 now open |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon 2020 & Horizon Europe.
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1331 articles available search in articlesHealth AI, data & cloud Deployment: Best use of technologies
Call for tender: Platform for Advanced Virtual Human Twin (VHT) Models
The European Commission has published a call for tender (procurement) under the Digital Europe programma for a Platform for Advanced Virtual Human Twin (VHT) Models. The main objective of this action is to develop a distributed platform making available to users a federated repository of VHTs related resources, a combined set of op... read more
Testimonial
BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
